BIO-AUTM Technology Transfer Symposium
Tuesday, May 4, 2010
2:00 PM – 5:30 PM
Hyatt at McCormick Place – Regency Ballroom B
2233 South Martin L. King Drive
The BIO Technology Transfer Symposium, in partnership with the Association of University Technology Managers (AUTM), will explore the role of universities in the U.S. innovation economy, with a particular emphasis on technology transfer. The Symposium will examine the opportunities and challenges of collaborative biotechnology research and licensing to heal, fuel, and feed the world. The Symposium provides a unique occasion for dialogue among a diverse group of university, company, investor, and policy thought leaders.
Seating is limited. To RSVP and for additional information, email firstname.lastname@example.org.
Download the Program Schedule. (743 KB PDF)
W. Mark Crowell, Vice President, Business Development, Scripps Research Institute; Co-chair, BIO Technology Transfer Committee
Linda P.B. Katehi, Chancellor, University of California (Davis)
Steve Mento, President & CEO, Conatus Pharmaceuticals Inc.
Robin A. Chadwick, Schwegman, Lundberg & Woessner (SLW)
Andrew Cittadine, Co-founder & CEO, American BioOptics
Tom Skalak, Vice President for Research, University of Virginia
Wes Blakeslee, Executive Director, Johns Hopkins University Office of Technology Transfer
Polly Murphy, Vice President Business Development, Pfizer
Eric Risser, Vice President for Business Development, Macrogenics
Mark Rohrbaugh, Director, National Institutes of Health Office of Technology Transfer
Jon Soderstrom, Ph.D., Managing Director, Office of Cooperative Research, Yale University
The BIO-AUTM Symposium is sponsored by Schwegman, Lundberg & Woessner and Sunlight Research (SLW/Sunlight). BIO Thanks SLW/Sunlight for additionally co-sponsoring the BIO-EPO IP Counsels Reception.